Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $0.21 by 618.31 percent. This is a 15200 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $77.114 million which beat the analyst consensus estimate of $74.845 million by 3.03 percent. This is a 28.81 percent increase over sales of $59.867 million the same period last year.